Corteva, Inc., a publicly traded, global pure-play agriculture company, has announced a definitive agreement to acquire Houston-based Stoller Group, Inc., one of the largest independent Biologicals companies in the industry. With operations and sales in more than 60 countries and 2022 forecasted revenues of more than US$400 million, Stoller brings immediate scale and profitability, with EBITDA margins that will be accretive to Corteva.
The acquisition of Stoller reinforces Corteva’s commitment to providing farmers with Biological tools that complement evolving farming practices and help them meet changing market expectations. Stoller’s superior reputation for farmer relationships and demand creation centers around a commercial model that’s built upon sharing knowledge with the channel and farmers. Stoller has been successful by demonstrating technical excellence and delivering benefits and value of integrated solutions in the field.
Latham & Watkins LLP represents Stoller Group in the transaction with a Houston-based corporate team led by partners John Greer and Ryan Maierson, with associates Bryan Ryan, Jordan Mack, Brent Wagner, Morgen Seim, Vera Bespalova, and Jordan Armstrong. Advice was also provided on tax matters by Houston partner Jim Cole, with associate Christine Mainguy; on benefits & compensation matters by Washington, D.C. partner Adam Kestenbaum; on antitrust matters by Washington, D.C. partner Jason Cruise and associate Mary Casale, Frankfurt partner Max Hauser and associate Nicolas Jung, and Madrid counsel José María Alonso; on sanctions matters by Washington, D.C. counsel Andrew Galdes, with associate Kristen Haight; on anti-corruption matters by New York partner Matthew Salerno; on environmental matters by Los Angeles/Houston counsel Joshua Marnitz, with associate Andy Landolfi; and on intellectual property and data privacy & security matters by Bay Area partner Michelle Gross, with associate Amy Tosi.